Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 15, 2018
15th Annual Biopharmaceutical Manufacturing Report and Survey from BioPlan Associates.
read more
WASHINGTON (AP) — President Barack Obama's effort to curb the use of antibiotics in animals raised for meat is starting with his own employees.
read more
Albumedix and Hebei Changshan Biochem Pharma Co., Ltd (Changshan) today announced that they have entered into a supply agreement for the development of a novel type II diabetes treatment that enables once-weekly dosing.
read more
Monday, November 07, 2016
GE Healthcare’s Life Sciences business and Valneva SE, a fully integrated vaccine biotech company, are sharing the results of a successful collaboration to optimize virus productivity in Valneva’s EB66® cell-line, a proprietary technology for the ...
read more
StarLIMS has agreed to acquire the MODA® Platform, a solution for manufacturing quality assurance and control in regulated environments. The transaction is expected to close in Q2 2026, subject to customary closing conditions.
read more
Dante Labs, Cambridge Cancer Genomics, and Nonacus, a provider of genetic testing products for precision medicine and liquid biopsy, have signed a collaboration agreement.
read more
Wednesday, September 23, 2020
Vaccinex has entered into a collaboration agreement with Merck through a subsidiary, to evaluate the combination of Vaccinex’s investigational SEMA4D inhibitor, pepinemab and KEYTRUDA for advanced, recurrent or metastatic head and neck squamous cell ...
read more
Wednesday, August 09, 2023
Emergent BioSolutions announced it is reducing investment in and de-emphasizing focus on growth in its CDMO services business. As a result, Emergent is reducing operations at its Bayview facility in Baltimore, Maryland.
read more
Switzerland-based CARBOGEN AMCIS announced the successful completion of the first inspection by the French regulatory authority, ANSM (Agence nationale de sécurité du médicament et des produits de santé), at its state-of-the-art sterile drug product ...
read more
Monday, November 12, 2018
Manufacturing inspections are one of the FDA’s most important tools for ensuring the quality of pharmaceutical products used by American patients.
read more
Wednesday, April 18, 2018
Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology.
read more
Tuesday, January 27, 2026
Evestia Clinical announced the acquisition of ICRC-Weyer GmbH, a Berlin-based, long-established CRO and scientific consultancy. The acquisition strengthens Evestia Clinical's presence in Germany and Europe and further enhances the company's full-...
read more
Wednesday, November 10, 2021
Anavasi Diagnostics announces it has been awarded $14.9 million from the NIH Rapid Acceleration of Diagnostics initiative.
read more
PAREXEL International Corporation, a global biopharmaceutical services provider has announced the launch of its patient sensor solution, a new offering that securely captures, transmits, stores, and visualizes study subject data in clinical trials.
read more
Alongside its dynamic growth, Vetter announced that it achieved its sustainability goals for 2023. The Contract Development & Manufacturing Organization (CDMO) recently became a member of SBTi and is therefore committed to meeting strict CO2 ...
read more